Health
Vaccine wars escalate as new antibody escape variants raise the bar – Medical Xpress
When a new mutation within the SARS-CoV-2 spike protein receptor binding domain (RBD) emerges that a particular antibody can no longer neutralyze, it is often called…
When a new mutation within the SARS-CoV-2 spike protein receptor binding domain (RBD) emerges that a particular antibody can no longer neutralyze, it is often called an escape variant. With the rapid identification of these new variants within the infected population, and also in lab-generated versions of the spike protein, an exhaustive escape variant matrix has begun to take shape. The good news is that as long as the actual antibody responses of vaccinated individuals are tested and verified,…
-
General20 hours agoWondering about winter | The Spectator Australia
-
Noosa News18 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General18 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Business24 hours agoAre Domain Holdings shares undervalued?